AKT1 and neoplasm: UBE2T overexpression has been indicated to enhance the PI3K-AKT pathway activity in multiple cancers, worsening tumor malignancy by increasing the phosphorylation of key components, such as PI3K, Akt, and mTOR, and regulating downstream genes associated with cell survival and anti-apoptosis.